ForFarmers NV (0RHZ)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 5.740 |
|---|---|
| 52-week range | 3.964 – 6.613 |
| Return, 1 month / 3 months | −5.4% / −3.9% |
| Return, 1 year / 3 years | +40.6% / +178.2% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 24.7% |
| Worst drawdown (1 year) | -16.5% |
| Average daily value traded | 0.05M EUR |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ForFarmers is a Dutch animal feed company based in Lochem that makes and supplies compound feed and related nutrition products for livestock farming. Its customers are farmers and livestock producers, and its feed serves dairy cattle, pigs, poultry and other farm animals. The company also offers advice and support services connected with animal nutrition. It operates across several European countries, including the Netherlands, Germany, Belgium and the United Kingdom, serving agricultural businesses in those markets.
ForFarmers NV trades under the code 0RHZ on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ForFarmers NV (0RHZ) trades on the London Exchange in UK. It last closed at EUR 5.740 on 21 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,745 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.6% and over the last three months it fell 3.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.0% | ||
| From 52-week high | -12.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.9% | ||
| 6-month return | -4.7% | ||
| 12-month return, skipping the last month | 48.7% | ||
| Stability (higher is calmer) | 79 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.5% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −5.4% |
| 3 months | −3.9% |
| 6 months | −4.7% |
| 1 year | +40.6% |
| 3 years | +178.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 5.781 / 5.918 |
|---|---|
| Golden / death cross (60 days) | Death, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.096 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Apr 2026 | EUR 0.3000 |
| 23 Apr 2025 | EUR 0.2000 |
| 15 Apr 2024 | EUR 0.1500 |
| 17 Apr 2023 | EUR 0.2000 |
| 20 Apr 2022 | EUR 0.1900 |
| 27 Apr 2021 | EUR 0.2900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.